• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性型脱发的干预措施。

Interventions for Female Pattern Hair Loss.

机构信息

Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands.

Bahrain Branch of Cochrane, Awali, Bahrain.

出版信息

JAMA Dermatol. 2017 Mar 1;153(3):329-330. doi: 10.1001/jamadermatol.2016.5790.

DOI:10.1001/jamadermatol.2016.5790
PMID:28114675
Abstract

CLINICAL QUESTION

Which interventions are effective and safe for treating female pattern hair loss (FPHL)?

BOTTOM LINE

There was low- to moderate-quality evidence that topical minoxidil (2% and 5%) was associated with improvements in FPHL. There was low-quality evidence that finasteride was no more effective than placebo. There were inconsistent results from studies that laser devices were effective, but total hair count increased compared with baseline (moderate- to low-quality evidence). Most treatments were not associated with higher adverse event rates than placebo.

摘要

临床问题

哪些干预措施对于治疗女性型脱发(FPHL)既有效又安全?

结论

低到中等质量的证据表明,外用米诺地尔(2%和 5%)与 FPHL 的改善相关。低质量的证据表明,非那雄胺并不比安慰剂更有效。激光设备有效的研究结果不一致,但与基线相比,总发量增加(中等至低质量证据)。与安慰剂相比,大多数治疗方法并未导致更高的不良事件发生率。

相似文献

1
Interventions for Female Pattern Hair Loss.女性型脱发的干预措施。
JAMA Dermatol. 2017 Mar 1;153(3):329-330. doi: 10.1001/jamadermatol.2016.5790.
2
Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.0.25%非那雄胺和 3%米诺地尔联合外用治疗女性型脱发的疗效:一项随机、双盲、对照研究。
Am J Clin Dermatol. 2019 Feb;20(1):147-153. doi: 10.1007/s40257-018-0387-0.
3
The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.与局部外用米诺地尔联合口服非那雄胺相比,局部外用米诺地尔联合口服螺内酯治疗女性雄激素性脱发、女性和男性脱发模式的疗效:一项双盲随机临床试验。
J Cosmet Dermatol. 2024 Feb;23(2):543-551. doi: 10.1111/jocd.15979. Epub 2023 Aug 31.
4
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.男性型和女性型脱发的诊断和治疗指南,2017 年版。
J Dermatol. 2018 Sep;45(9):1031-1043. doi: 10.1111/1346-8138.14470. Epub 2018 Jun 4.
5
Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.非那雄胺及其治疗女性型脱发的潜力:现有证据。
Drug Des Devel Ther. 2020 Mar 2;14:951-959. doi: 10.2147/DDDT.S240615. eCollection 2020.
6
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.雄激素性脱发治疗方法的疗效:系统评价和荟萃分析。
J Am Acad Dermatol. 2017 Jul;77(1):136-141.e5. doi: 10.1016/j.jaad.2017.02.054. Epub 2017 Apr 7.
7
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.一项关于5%和2%外用米诺地尔溶液治疗女性型脱发的随机、安慰剂对照试验。
J Am Acad Dermatol. 2004 Apr;50(4):541-53. doi: 10.1016/j.jaad.2003.06.014.
8
A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia.一项关于在生育期和绝经后女性的雄激素性脱发患者中,使用单一或联合口服或局部非那雄胺治疗的临床试验的系统评价。
Adv Clin Exp Med. 2023 Jul;32(7):813-823. doi: 10.17219/acem/157990.
9
Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review.基于证据的女性型脱发治疗方法:Cochrane 系统评价综述。
Br J Dermatol. 2012 Nov;167(5):995-1010. doi: 10.1111/j.1365-2133.2012.11166.x. Epub 2012 Oct 5.
10
An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.口服非那雄胺与5%外用米诺地尔治疗男性雄激素性脱发的开放性、随机对照研究
Dermatology. 2004;209(2):117-25. doi: 10.1159/000079595.

引用本文的文献

1
Development of Ethosomes for the Topical Treatment of Androgenic Alopecia: Ethanol Effect on Dutasteride Targeting to the Hair Follicles.用于雄激素性脱发局部治疗的醇质体的研发:乙醇对度他雄胺靶向毛囊的影响
Pharmaceutics. 2025 Jun 17;17(6):786. doi: 10.3390/pharmaceutics17060786.
2
The Future of Alopecia Treatment: Plant Extracts, Nanocarriers, and 3D Bioprinting in Focus.脱发治疗的未来:聚焦植物提取物、纳米载体和3D生物打印
Pharmaceutics. 2025 Apr 29;17(5):584. doi: 10.3390/pharmaceutics17050584.
3
Bicalutamide 25 mg combined with minoxidil 1 mg versus minoxidil 1 mg for female pattern hair loss: A randomized double-blind clinical trial.
比卡鲁胺25毫克联合米诺地尔1毫克与米诺地尔1毫克治疗女性型脱发的随机双盲临床试验。
JAAD Int. 2025 Jan 10;19:48-55. doi: 10.1016/j.jdin.2024.12.002. eCollection 2025 Apr.
4
Approaches to management of endocrine therapy-induced alopecia in breast cancer patients.乳腺癌患者内分泌治疗所致脱发的管理方法。
Support Care Cancer. 2025 Feb 17;33(3):199. doi: 10.1007/s00520-025-09258-3.
5
Topical dutasteride for androgenic alopecia: current state and prospects.外用度他雄胺治疗雄激素性脱发:现状与前景
Ther Deliv. 2025 Mar;16(3):271-283. doi: 10.1080/20415990.2024.2437973. Epub 2024 Dec 6.
6
Randomized Clinical Trial to Evaluate the Effect of Probiotic Intake on Androgenic Alopecia.随机临床试验评估益生菌摄入对雄激素性脱发的影响。
Nutrients. 2024 Aug 30;16(17):2900. doi: 10.3390/nu16172900.
7
Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern Hair Loss.头皮分割对照试验,评估 0.5%米诺地尔 MMP®与 5%米诺地尔局部治疗女性型脱发的疗效。
Arch Dermatol Res. 2024 Jun 1;316(6):313. doi: 10.1007/s00403-024-03053-6.
8
Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects - A 16-Week Randomized, Placebo-Controlled Study.标准化锯棕榈油的口服和局部给药可减少雄激素性脱发患者的脱发并促进头发生长——一项为期16周的随机、安慰剂对照研究。
Clin Cosmet Investig Dermatol. 2023 Nov 11;16:3251-3266. doi: 10.2147/CCID.S435795. eCollection 2023.
9
Female-pattern hair loss: therapeutic update.女性型脱发:治疗进展。
An Bras Dermatol. 2023 Jul-Aug;98(4):506-519. doi: 10.1016/j.abd.2022.09.006. Epub 2023 Mar 30.
10
Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review.毛囊中的磺基转移酶SULT1A1活性:雄激素性秃发患者对米诺地尔治疗反应的预后标志物综述
Postepy Dermatol Alergol. 2022 Jun;39(3):472-478. doi: 10.5114/ada.2020.99947. Epub 2020 Oct 16.